Cancer and tumour-related conditions often develop silently, with noticeable symptoms appearing only once the disease has progressed. Early detection is therefore essential, as it can significantly improve treatment outcomes and prognosis. Tumour-associated markers are substances produced either by cancerous cells or by the body in response to cancer. These markers can be measured in the blood and provide valuable insights for early detection, ongoing monitoring, and personalised treatment planning. While not definitive diagnostic tools on their own, they form a crucial part of a broader cancer screening and surveillance strategy.

At Solasta Healthcare, our Tumour-Associated Marker Blood Test provides a comprehensive assessment of key cancer biomarkers. By analysing these markers, your doctor can gain additional information about the risk of tumour development, the progression of existing conditions, and the effectiveness of treatments. Early identification of abnormal marker levels allows for timely medical intervention, improving patient outcomes and supporting long-term health.

Your doctor may recommend a Tumour-Associated Marker Blood Test if you have a family history of cancer, unexplained weight loss, persistent fatigue, unusual lumps or swelling, digestive changes, or if you are undergoing post-treatment monitoring to assess therapy response or detect cancer recurrence. Early testing is crucial to identify potential issues before complications arise and to guide decisions regarding further investigation or intervention.